Cargando…

Effects of crystalloid, hyper-oncotic albumin, and iso-oncotic albumin on lung and kidney damage in experimental acute lung injury

BACKGROUND: Conflicting data have reported beneficial effects of crystalloids, hyper-oncotic albumin (20%ALB), and iso-oncotic albumin (5%ALB) in critically ill patients. Although hyper-oncotic albumin may minimize lung injury, recent studies have shown that human albumin may lead to kidney damage p...

Descripción completa

Detalles Bibliográficos
Autores principales: Mendes, Renata de S., Oliveira, Milena V., Padilha, Gisele A., Rocha, Nazareth N., Santos, Cintia L., Maia, Ligia A., Fernandes, Marcos V. de S., Cruz, Fernanda F., Olsen, Priscilla C., Capelozzi, Vera L., de Abreu, Marcelo Gama, Pelosi, Paolo, Rocco, Patricia R. M., Silva, Pedro L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636113/
https://www.ncbi.nlm.nih.gov/pubmed/31311539
http://dx.doi.org/10.1186/s12931-019-1115-x
_version_ 1783436006607814656
author Mendes, Renata de S.
Oliveira, Milena V.
Padilha, Gisele A.
Rocha, Nazareth N.
Santos, Cintia L.
Maia, Ligia A.
Fernandes, Marcos V. de S.
Cruz, Fernanda F.
Olsen, Priscilla C.
Capelozzi, Vera L.
de Abreu, Marcelo Gama
Pelosi, Paolo
Rocco, Patricia R. M.
Silva, Pedro L.
author_facet Mendes, Renata de S.
Oliveira, Milena V.
Padilha, Gisele A.
Rocha, Nazareth N.
Santos, Cintia L.
Maia, Ligia A.
Fernandes, Marcos V. de S.
Cruz, Fernanda F.
Olsen, Priscilla C.
Capelozzi, Vera L.
de Abreu, Marcelo Gama
Pelosi, Paolo
Rocco, Patricia R. M.
Silva, Pedro L.
author_sort Mendes, Renata de S.
collection PubMed
description BACKGROUND: Conflicting data have reported beneficial effects of crystalloids, hyper-oncotic albumin (20%ALB), and iso-oncotic albumin (5%ALB) in critically ill patients. Although hyper-oncotic albumin may minimize lung injury, recent studies have shown that human albumin may lead to kidney damage proportional to albumin concentration. In this context, we compared the effects of Ringer’s lactate (RL), 20%ALB, and 5%ALB, all titrated according to similar hemodynamic goals, on pulmonary function, lung and kidney histology, and molecular biology in experimental acute lung injury (ALI). METHODS: Male Wistar rats received Escherichia coli lipopolysaccharide intratracheally (n = 24) to induce ALI. After 24 h, animals were anesthetized and randomly assigned to receive RL, 20%ALB, or 5%ALB (n = 6/group) to maintain hemodynamic stability (distensibility index of inferior vena cava < 25%, mean arterial pressure > 65 mmHg). Rats were then mechanically ventilated for 6 h. Six animals, which received neither ventilation nor fluids (NV), were used for molecular biology analyses. RESULTS: The total fluid volume infused was higher in RL compared to 5%ALB and 20%ALB (median [interquartile range], 10.8[8.2–33.2] vs. 4.8[3.6–7.7] and 4.3[3.9–6.6] mL, respectively; p = 0.02 and p = 0.003). B-line counts on lung ultrasound (p < 0.0001 and p = 0.0002) and serum lactate levels (p = 0.01 and p = 0.01) were higher in RL than 5%ALB and 20%ALB. Diffuse alveolar damage score was lower in 5%ALB (10.5[8.5–12]) and 20%ALB (10.5[8.5–14]) than RL (16.5[12.5–20.5]) (p < 0.05 and p = 0.03, respectively), while acute kidney injury score was lower in 5%ALB (9.5[6.5–10]) than 20%ALB (18[15–28.5], p = 0.0006) and RL (16 [15–19], p = 0.04). In lung tissue, mRNA expression of interleukin (IL)-6 was higher in RL (59.1[10.4–129.3]) than in 5%ALB (27.0[7.8–49.7], p = 0.04) or 20%ALB (3.7[7.8–49.7], p = 0.03), and IL-6 protein levels were higher in RL than 5%ALB and 20%ALB (p = 0.026 and p = 0.021, respectively). In kidney tissue, mRNA expression and protein levels of kidney injury molecule (KIM)-1 were lower in 5%ALB than RL and 20%ALB, while nephronectin expression increased (p = 0.01 and p = 0.01), respectively. CONCLUSIONS: In a rat model of ALI, both iso-oncotic and hyper-oncotic albumin solutions were associated with less lung injury compared to Ringer’s lactate. However, hyper-oncotic albumin resulted in greater kidney damage than iso-oncotic albumin. This experimental study is a step towards future clinical designs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12931-019-1115-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6636113
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66361132019-07-25 Effects of crystalloid, hyper-oncotic albumin, and iso-oncotic albumin on lung and kidney damage in experimental acute lung injury Mendes, Renata de S. Oliveira, Milena V. Padilha, Gisele A. Rocha, Nazareth N. Santos, Cintia L. Maia, Ligia A. Fernandes, Marcos V. de S. Cruz, Fernanda F. Olsen, Priscilla C. Capelozzi, Vera L. de Abreu, Marcelo Gama Pelosi, Paolo Rocco, Patricia R. M. Silva, Pedro L. Respir Res Research BACKGROUND: Conflicting data have reported beneficial effects of crystalloids, hyper-oncotic albumin (20%ALB), and iso-oncotic albumin (5%ALB) in critically ill patients. Although hyper-oncotic albumin may minimize lung injury, recent studies have shown that human albumin may lead to kidney damage proportional to albumin concentration. In this context, we compared the effects of Ringer’s lactate (RL), 20%ALB, and 5%ALB, all titrated according to similar hemodynamic goals, on pulmonary function, lung and kidney histology, and molecular biology in experimental acute lung injury (ALI). METHODS: Male Wistar rats received Escherichia coli lipopolysaccharide intratracheally (n = 24) to induce ALI. After 24 h, animals were anesthetized and randomly assigned to receive RL, 20%ALB, or 5%ALB (n = 6/group) to maintain hemodynamic stability (distensibility index of inferior vena cava < 25%, mean arterial pressure > 65 mmHg). Rats were then mechanically ventilated for 6 h. Six animals, which received neither ventilation nor fluids (NV), were used for molecular biology analyses. RESULTS: The total fluid volume infused was higher in RL compared to 5%ALB and 20%ALB (median [interquartile range], 10.8[8.2–33.2] vs. 4.8[3.6–7.7] and 4.3[3.9–6.6] mL, respectively; p = 0.02 and p = 0.003). B-line counts on lung ultrasound (p < 0.0001 and p = 0.0002) and serum lactate levels (p = 0.01 and p = 0.01) were higher in RL than 5%ALB and 20%ALB. Diffuse alveolar damage score was lower in 5%ALB (10.5[8.5–12]) and 20%ALB (10.5[8.5–14]) than RL (16.5[12.5–20.5]) (p < 0.05 and p = 0.03, respectively), while acute kidney injury score was lower in 5%ALB (9.5[6.5–10]) than 20%ALB (18[15–28.5], p = 0.0006) and RL (16 [15–19], p = 0.04). In lung tissue, mRNA expression of interleukin (IL)-6 was higher in RL (59.1[10.4–129.3]) than in 5%ALB (27.0[7.8–49.7], p = 0.04) or 20%ALB (3.7[7.8–49.7], p = 0.03), and IL-6 protein levels were higher in RL than 5%ALB and 20%ALB (p = 0.026 and p = 0.021, respectively). In kidney tissue, mRNA expression and protein levels of kidney injury molecule (KIM)-1 were lower in 5%ALB than RL and 20%ALB, while nephronectin expression increased (p = 0.01 and p = 0.01), respectively. CONCLUSIONS: In a rat model of ALI, both iso-oncotic and hyper-oncotic albumin solutions were associated with less lung injury compared to Ringer’s lactate. However, hyper-oncotic albumin resulted in greater kidney damage than iso-oncotic albumin. This experimental study is a step towards future clinical designs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12931-019-1115-x) contains supplementary material, which is available to authorized users. BioMed Central 2019-07-16 2019 /pmc/articles/PMC6636113/ /pubmed/31311539 http://dx.doi.org/10.1186/s12931-019-1115-x Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Mendes, Renata de S.
Oliveira, Milena V.
Padilha, Gisele A.
Rocha, Nazareth N.
Santos, Cintia L.
Maia, Ligia A.
Fernandes, Marcos V. de S.
Cruz, Fernanda F.
Olsen, Priscilla C.
Capelozzi, Vera L.
de Abreu, Marcelo Gama
Pelosi, Paolo
Rocco, Patricia R. M.
Silva, Pedro L.
Effects of crystalloid, hyper-oncotic albumin, and iso-oncotic albumin on lung and kidney damage in experimental acute lung injury
title Effects of crystalloid, hyper-oncotic albumin, and iso-oncotic albumin on lung and kidney damage in experimental acute lung injury
title_full Effects of crystalloid, hyper-oncotic albumin, and iso-oncotic albumin on lung and kidney damage in experimental acute lung injury
title_fullStr Effects of crystalloid, hyper-oncotic albumin, and iso-oncotic albumin on lung and kidney damage in experimental acute lung injury
title_full_unstemmed Effects of crystalloid, hyper-oncotic albumin, and iso-oncotic albumin on lung and kidney damage in experimental acute lung injury
title_short Effects of crystalloid, hyper-oncotic albumin, and iso-oncotic albumin on lung and kidney damage in experimental acute lung injury
title_sort effects of crystalloid, hyper-oncotic albumin, and iso-oncotic albumin on lung and kidney damage in experimental acute lung injury
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636113/
https://www.ncbi.nlm.nih.gov/pubmed/31311539
http://dx.doi.org/10.1186/s12931-019-1115-x
work_keys_str_mv AT mendesrenatades effectsofcrystalloidhyperoncoticalbuminandisooncoticalbuminonlungandkidneydamageinexperimentalacutelunginjury
AT oliveiramilenav effectsofcrystalloidhyperoncoticalbuminandisooncoticalbuminonlungandkidneydamageinexperimentalacutelunginjury
AT padilhagiselea effectsofcrystalloidhyperoncoticalbuminandisooncoticalbuminonlungandkidneydamageinexperimentalacutelunginjury
AT rochanazarethn effectsofcrystalloidhyperoncoticalbuminandisooncoticalbuminonlungandkidneydamageinexperimentalacutelunginjury
AT santoscintial effectsofcrystalloidhyperoncoticalbuminandisooncoticalbuminonlungandkidneydamageinexperimentalacutelunginjury
AT maialigiaa effectsofcrystalloidhyperoncoticalbuminandisooncoticalbuminonlungandkidneydamageinexperimentalacutelunginjury
AT fernandesmarcosvdes effectsofcrystalloidhyperoncoticalbuminandisooncoticalbuminonlungandkidneydamageinexperimentalacutelunginjury
AT cruzfernandaf effectsofcrystalloidhyperoncoticalbuminandisooncoticalbuminonlungandkidneydamageinexperimentalacutelunginjury
AT olsenpriscillac effectsofcrystalloidhyperoncoticalbuminandisooncoticalbuminonlungandkidneydamageinexperimentalacutelunginjury
AT capelozziveral effectsofcrystalloidhyperoncoticalbuminandisooncoticalbuminonlungandkidneydamageinexperimentalacutelunginjury
AT deabreumarcelogama effectsofcrystalloidhyperoncoticalbuminandisooncoticalbuminonlungandkidneydamageinexperimentalacutelunginjury
AT pelosipaolo effectsofcrystalloidhyperoncoticalbuminandisooncoticalbuminonlungandkidneydamageinexperimentalacutelunginjury
AT roccopatriciarm effectsofcrystalloidhyperoncoticalbuminandisooncoticalbuminonlungandkidneydamageinexperimentalacutelunginjury
AT silvapedrol effectsofcrystalloidhyperoncoticalbuminandisooncoticalbuminonlungandkidneydamageinexperimentalacutelunginjury